In agreement with our earlier studies, we found that the in vitro silencing of STK25 in human hepatoma cells suppressed proliferation, migration, and invasion,18 and the effect was equal to that achieved by incubating cells with sorafenib or regorafenib, which are widely used anti-HCC drugs in current clinical practice. This evidence concerns the gene STK25 and hepatocellular carcinoma.